Adaptive neuromodulation dialogues: navigating current challenges and emerging innovations in neuromodulation system...

Area of Science:

• Neurotechnology
• Biomedical Engineering
• Neuroscience

Background:

• Adaptive neuromodulation and brain-computer interfaces (BCIs) are rapidly advancing from prototypes to clinical use.
• Increased public and scientific attention necessitates rigorous evaluation of safety, efficacy, and ethical considerations.
• Expert discussions identified critical domains for therapeutic neurotechnology development.

Purpose of the Study:

• To synthesize expert insights into five key domains for developing therapeutic neuromodulation and BCI devices.
• To emphasize the importance of translational research platforms for iterative testing and validation.
• To address the multifaceted challenges including technological design, clinical needs, neural mechanisms, and ethical responsibilities.

Main Methods:

• Synthesis of expert discussions and insights.
• Analysis of the current landscape of neuromodulation devices and translational platforms.
• Examination of clinical needs, neural mechanisms, technology design, and ethical concerns.

Main Results:

• Identification of five essential domains for therapeutic device development: landscape analysis, clinical need, neural mechanisms, technology design, and ethics.
• Emphasis on translational research platforms balancing flexibility, safety, and clinical benefit.
• Exploration of requirements for interoperability, modularity, wireless communication, regulatory processes, funding, and ethical obligations.

Conclusions:

• Therapeutic neurotechnology development requires a holistic approach integrating scientific, engineering, and clinical perspectives.
• Translational platforms are crucial for rapid, iterative testing while prioritizing patient safety and benefit.
• Active patient involvement and long-term ethical considerations are paramount for successful neurotechnology implementation.